Clinical Trial Update: An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and tolerability of topiramate in obese patients with binge eating disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Janssen-Cilag Farmaceutica Ltda. | Conditions: Binge Eating | Phase 3 | Status: COMPLETED